FDA Drug Watch System May "Confuse" Consumers In Proposed Form - CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA should include drug safety information on its new Drug Watch system only after a review has "fully determined the significance of the information, causal or otherwise," according to the Consumer Healthcare Products Association